Volume 16, Number 5—May 2010
Letter
Sorbitol-fermenting Escherichia coli O157, Scotland
Kevin G.J. Pollock
, Mary E. Locking, T. James Beattie, Heather Maxwell, Ian Ramage, David Hughes, Jennifer Cowieson, Lesley Allison, Mary Hanson, and John M. Cowden
, Mary E. Locking, T. James Beattie, Heather Maxwell, Ian Ramage, David Hughes, Jennifer Cowieson, Lesley Allison, Mary Hanson, and John M. CowdenTable
Characteristics of patients infected with non–SF-O157 versus SF-O157 Escherichia coli, Scotland, 2006*
| Characteristic |
SF-O157,
n = 8 |
Non–SF-O157,
n = 19 |
p value |
|---|---|---|---|
| Age, y ± SEM | 5.4 ± 1.4 | 5.1 ± 0.9 | |
| Sign or symptom, no. (%) patients | |||
| Diarrhea | 8 | 19 | |
| Bloody diarrhea | 6 (75) | 14 (74) | 0.79 |
| Abdominal pain | 6 (75) | 13 (68) | 0.13 |
| Fever | 1 (12) | 4 (21) | 0.73 |
| Neurologic involvement |
2 (25) |
4 (21) |
0.82 |
| Clinical parameter, mean ± SEM | |||
| Anuria, d | 11.7 ± 2.7 | 7.9 ± 1.4 | 0.20 |
| Leukocyte count, ×109/L | 26.4 ± 2.1 | 36.4 ± 10.1 | 0.34 |
| C-reactive protein, mg/L | 65.6 ± 27.1 | 93.4 ± 23.1 | 0.31 |
| Serum albumin, g/L | 32.4 ± 7.0 | 23.2 ± 1.0 | 0.03 |
| Lactate dehydrogenase, IU/L | 2,774 ± 280 | 2,556 ± 324 | 0.68 |
| Hospital stay, d |
17.9 ± 3.7 |
16.1 ± 2.9 |
0.71 |
| Treatment, mean no. sessions ± SEM | |||
| Peritoneal dialysis | 13.4 ± 2.3 | 7.4 ± 1.9 | 0.07 |
| Hemodialysis |
20.5 ± 3.5 |
9.3 ± 1.3 |
0.01 |
| Outcomes, 1 y follow-up, no. | n = 6 | n = 19 | |
| Full recovery, no. patients | 6 | 17 | |
| Clinical sequelae, no. patients | 0 | 2† |
*SF, sorbitol-fermenting.
†1 with hypertension, 1 with abdominal pain/vomiting.
